What question did this study set out to answer?

This research aims to evaluate the clinical efficacy and safety of autologous fibrin sealant Vivostat in neurosurgery.

April 5, 2026Burdenko s Journal of Neurosurgery0 citations

First clinical application of autologous fibrin sealant Vivostat for neurosurgery in Kazakhstan and Central Asia

EKE.N. KuanyshevNational Center of Neurology and Psychiatry BSB.S. SyzdykovaNational Center of Neurology and Psychiatry DTD TeltayevNational Center of Neurology and Psychiatry

Key Points

This research aims to evaluate the clinical efficacy and safety of autologous fibrin sealant Vivostat in neurosurgery.
Conducted first clinical application in Kazakhstan and Central Asia
Evaluated efficacy for dural sealing and skull base reconstruction
Assessed postoperative outcomes including CSF leakage and reoperation rates
Demonstrated high efficacy in sealing dural membranes
Reduced risk of postoperative CSF leakage compared to previous methods
Low rates of reoperation following application of Vivostat

Abstract

The use of autologous fibrin sealant Vivostat demonstrated high efficacy and safety for dural sealing and skull base reconstruction. The method reduced the risk of postoperative CSF leakage and reoperation. This study presents the first clinical experience with Vivostat in Central Asia.

KI fragen

Bookmark

View Full Paper